CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing [Phase 2]
Summary
Phase 2 clinical trial update for a pharmacological intervention targeting symptomatic mild sleep disordered breathing has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Sleep Disordered Breathing | Phase 2 | Status: COMPLETED